1. Home
  2. ACRV vs FATBB Comparison

ACRV vs FATBB Comparison

Compare ACRV & FATBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACRV
  • FATBB
  • Stock Information
  • Founded
  • ACRV 2018
  • FATBB 2017
  • Country
  • ACRV United States
  • FATBB United States
  • Employees
  • ACRV N/A
  • FATBB N/A
  • Industry
  • ACRV Medicinal Chemicals and Botanical Products
  • FATBB Restaurants
  • Sector
  • ACRV Health Care
  • FATBB Consumer Discretionary
  • Exchange
  • ACRV Nasdaq
  • FATBB Nasdaq
  • Market Cap
  • ACRV 40.4M
  • FATBB 44.6M
  • IPO Year
  • ACRV 2022
  • FATBB N/A
  • Fundamental
  • Price
  • ACRV $1.34
  • FATBB $2.72
  • Analyst Decision
  • ACRV Buy
  • FATBB
  • Analyst Count
  • ACRV 7
  • FATBB 0
  • Target Price
  • ACRV $17.60
  • FATBB N/A
  • AVG Volume (30 Days)
  • ACRV 379.9K
  • FATBB 3.6K
  • Earning Date
  • ACRV 08-12-2025
  • FATBB 01-01-0001
  • Dividend Yield
  • ACRV N/A
  • FATBB 10.57%
  • EPS Growth
  • ACRV N/A
  • FATBB N/A
  • EPS
  • ACRV N/A
  • FATBB N/A
  • Revenue
  • ACRV N/A
  • FATBB $582,704,000.00
  • Revenue This Year
  • ACRV N/A
  • FATBB N/A
  • Revenue Next Year
  • ACRV N/A
  • FATBB $8.68
  • P/E Ratio
  • ACRV N/A
  • FATBB N/A
  • Revenue Growth
  • ACRV N/A
  • FATBB 10.63
  • 52 Week Low
  • ACRV $1.05
  • FATBB $2.10
  • 52 Week High
  • ACRV $10.16
  • FATBB $5.18
  • Technical
  • Relative Strength Index (RSI)
  • ACRV 55.88
  • FATBB 54.41
  • Support Level
  • ACRV $1.15
  • FATBB $2.42
  • Resistance Level
  • ACRV $1.38
  • FATBB $2.75
  • Average True Range (ATR)
  • ACRV 0.09
  • FATBB 0.14
  • MACD
  • ACRV 0.02
  • FATBB 0.03
  • Stochastic Oscillator
  • ACRV 83.33
  • FATBB 86.36

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

About FATBB FAT Brands Inc. Class B

FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States.

Share on Social Networks: